Weller, Michael <br/><br/>
Prime time for molecular marker diagnostics in neuro-oncology.  [electronic resource] 

 -  Current opinion in neurology  Dec 2012 
 - 743-4 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-6551 
<br/><br/><label>Standard No.: </label>10.1097/WCO.0b013e32835a0247  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Brain Neoplasms--diagnosis<br/>Combined Modality Therapy<br/>DNA Methylation<br/>DNA Modification Methylases--genetics<br/>DNA Repair Enzymes--genetics<br/>Dacarbazine--analogs & derivatives<br/>Glioblastoma--diagnosis<br/>Humans<br/>Prognosis<br/>Promoter Regions, Genetic<br/>Radiotherapy<br/>Randomized Controlled Trials as Topic<br/>Temozolomide<br/>Treatment Outcome<br/>Tumor Suppressor Proteins--genetics